We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSRA
726
DELISTED
CSRA Inc.
CSRA
| $8.36M | 0.02% |
285,235
+8,684
| +3% | +$266K |
|
|
LSI
727
DELISTED
Life Storage, Inc.
LSI
| $8.35M | 0.02% |
152,549
-12,631
| -8% | -$708K |
|
|
WRI
728
DELISTED
Weingarten Realty Investors
WRI
| $8.31M | 0.02% |
248,788
+15,758
| +7% | +$550K |
|
729
Deluxe
DLX
$1.19B
| $8.29M | 0.02% |
114,815
+3,524
| +3% | +$258K |
|
730
EnerSys
ENS
$6.74B
| $8.27M | 0.02% |
104,727
+3,554
| +4% | +$277K |
|
731
Patterson-UTI
PTEN
$3.74B
| $8.26M | 0.02% |
340,374
+55,429
| +19% | +$1.49M |
|
|
VMW
732
DELISTED
VMware, Inc
VMW
| $8.21M | 0.02% |
89,085
+4,062
| +5% | +$358K |
|
|
UMPQ
733
DELISTED
Umpqua Holdings Corp
UMPQ
| $8.19M | 0.02% |
461,887
+15,189
| +3% | +$279K |
|
734
MKS Inc
MKSI
$19.8B
| $8.18M | 0.02% |
118,961
+31,111
| +35% | +$2.05M |
|
|
MASI
735
DELISTED
Masimo
MASI
| $8.18M | 0.02% |
87,658
+27,015
| +45% | +$2.22M |
|
736
Edgewell Personal Care
EPC
$1.26B
| $8.17M | 0.02% |
111,753
+3,255
| +3% | +$248K |
|
737
CoreCivic
CXW
$2.95B
| $8.14M | 0.02% |
259,129
+40,520
| +19% | +$1.24M |
|
|
SPR
738
DELISTED
Spirit AeroSystems
SPR
| $8.13M | 0.02% |
140,322
+2,619
| +2% | +$153K |
|
739
Manhattan Associates
MANH
$11.1B
| $8.12M | 0.02% |
156,090
+3,963
| +3% | +$200K |
|
740
Navient
NAVI
$794M
| $8.1M | 0.02% |
548,746
+13,950
| +3% | +$214K |
|
|
FLIR
741
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $8.09M | 0.02% |
223,084
+10,248
| +5% | +$369K |
|
742
Hanover Insurance
THG
$8.05B
| $8.08M | 0.02% |
89,751
+2,844
| +3% | +$252K |
|
743
Teradata
TDC
$2.88B
| $8.07M | 0.02% |
259,432
+8,495
| +3% | +$257K |
|
744
Encompass Health
EHC
$11B
| $8.07M | 0.02% |
236,926
+5,752
| +2% | +$189K |
|
745
Primerica
PRI
$10.1B
| $8.07M | 0.02% |
98,154
+1,797
| +2% | +$140K |
|
746
Landstar System
LSTR
$5.75B
| $8.07M | 0.02% |
94,175
+9,818
| +12% | +$839K |
|
747
Norwegian Cruise Line
NCLH
$8.59B
| $8.04M | 0.02% |
158,481
+9,417
| +6% | +$457K |
|
748
Warner Bros
WBD
$63.9B
| $8.02M | 0.02% |
275,789
+4,997
| +2% | +$140K |
|
749
First Horizon
FHN
$12.1B
| $8.01M | 0.02% |
432,903
+16,844
| +4% | +$331K |
|
750
Black Hills Corp
BKH
$5.5B
| $8.01M | 0.02% |
120,468
+3,028
| +3% | +$192K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.